Organo Gold Continues to be a Part of Modern Coffee Culture Through Its Unique Business Model

Coffee culture is something that you have to experience to fully understand, and Organo Gold has been a part of that culture for many years. It can be as easy as getting out and visiting a local coffee shop because coffee culture has as much to do with people as it does coffee. Coffee shops all around the world are always buzzing with energy and good times, but where did it all begin?

Organo Gold knows that to discover coffee culture’s roots in the United States, a person would have to go back to the 1960s in Greenwich Village. It can also be easily said that the west coast of the United States increased coffee culture in the 1980s and definitely in later years as popular chains like Starbucks grew. In reality, you could look much further back into the history of the U.S.A. like the 1800s when the first wave of coffee consumption hit the nation. In 1900, the entirety of coffee culture changed as instant coffee was invented.

Today, Organo Gold has been bringing a new wave of coffee beverages to people, and the company respects the coffee culture of the past and of today. Coffee has come a long way from its humble beginnings, and the company that was created in 2008 has been offering its customers one-cup brew packets, other coffee beverages, and tea products since its inception. Organo Gold employs a distribution method of selling its products and has aligned itself with distributors who work to sell its products to the general public. The nice thing about this business model is that local people can offer product samples to coffee shops and baristas and can earn a healthy living while doing so. By becoming more financially independent through selling something a person loves, they can become a real part of the history of coffee culture.

Destination To Visit While In Brazil According To Entrepreneur Guilherme Paulus

For hotelier, Guilherme Paulus vacations are all about service and having fun. This is the reason he has continued to scout for locations all over Brazil, despite having more than 19 of them. He is constantly talking about the numerous destinations that one can visit in Brazil and have a good time whether alone or with the family.

His company the GJP network has more than 3000 rooms cutting across the country, and one is sure to find quality service whenever they visit one of them. Guilherme Paulus owns the Prodigy Berrini located in Sao Paulo. Situated in one of the country’s largest cities, it has proved popular with those traveling on business and leisure. Its location makes ideal for those who value, convenience as it’s located near the central business district as well as the International Airport.

Read more: Guilherme Paulus É Eleito Empreendedor Do Ano

Prodigy Serrano, the Castle and Mountain, the Wish Serrano, and Prodigy Gramado are all located in Gramado. The number of hotels in this state says something about its popularity with tourist. The number of destinations is massive as its home to the Snowland Snow Park; this is the premier destination in Brazil for all winter related activities. It continues to attract tourist year in year out and has become one of the biggest tourist attractions in the country. The Black Lake is also located here; this is the Brazilian hub of water sports. From its location to the surrounding pines that give it the idealistic scenery, everything seems to fit perfectly.

When visiting Confins, Guilherme Paulus has the best location for you to stay and that is at Linx Confins. This is one of his pet projects as he happens to love this destination personally. The town has a rich history, given that it’s one of the first gold towns in the country. It is also a UNESCO Biosphere Reserve. This is one of those destinations that has been able to merge traditional Brazil and the new meticulously. This way anyone visiting can experience the contrast while staying at one of the best hotels Brazil has to offer. The businessman personally recommends that anyone visiting Brazil make an effort of coming here.

Check more about Guilherme Paulus: http://forbes.uol.com.br/negocios/2015/12/como-o-bilionario-guilherme-paulus-pretende-se-tornar-o-maior-hoteleiro-do-brasil/

Marathon Pharmaceuticals Helps Calm Children’s Needle Anxiety With New Anesthetic

Zingo is a device that provides a local anesthetic to help manage the pain of venous access. The device releases a powdered .5 mg dose of lidocaine to the site where doctors will use the needle. The device will numb the area in one to three minutes. The numbing effect only last around ten minutes. Giving doctors enough time to administer the shot, or blood draw without having any drawn-out effects. The device can numb a patient faster than local anesthetic which can take 30 to 60 minutes to work. This time frame makes it difficult to incorporate anesthetic at the doctor’s office. Zingo, created for children who often have a fear of needles, helps ease anxiety. The device will help ease a child’s pain, and anxiety when they have to get a shoot, have an IV placed or get blood drawn. (thenewsversion)

 

The creators of Zingo are Marathon Pharmaceuticals. Marathon Pharmaceuticals partnered with Medline to help distribute and market Zingo. The mutual goal of both companies is to help reduce anxiety and pain in children. They distributed the device to children and community hospitals, and medical centers.

 

Marathon Pharmaceuticals works with patients that have unmet medical needs. The company specializes in small volume hard to manufacture medicines. Some other drugs that Marathon Pharmaceuticals have created include Amytal Sodium a barbiturate derivative that is used to help insomnia patients. The drug decreases motor activity and produces drowsiness and sedation. Marathon Pharmaceuticals makes another barbiturate derivative called Seconal Sodium. This drug helps insomnia patients and is used as a pre-anesthetic.

 

Marathon Pharmaceuticals has a main office located in Northbrook, Illinois. They also have offices in Chicago and New Jersey. The company also has a Bioscience Center located in Chicago. At the Bioscience Center research is conducted on cancer, central nervous diseases, gastrointestinal diseases, and endocrine deficiencies. The research will help Marathon Pharmaceuticals provide better medical care for patients with rare disorders.

 

 

Jeffrey Aronin Is Bringing Rare Disease Treatments Into The Mainstream

Jeffrey Aronin has been a developer, a visionary, and entrepreneur of international biotech and healthcare innovative companies for 20 years. He is a brilliant mind in the field of complex science and drug development projects that are designed specifically to address the much needed medical concerns of patients who suffer from rare unaddressed diseases.

 

Mr. Aronin has had many new medicines and technological innovations approved that are used around the world. He presently serves as the Chief Executive Officer and Chairman of Paragon Biosciences. Paragon Biosciences meets the goals and designs of Jeffrey which is to help patients with debilitating diseases live better lives by using his biotech products.

 

Jeffrey and Paragon are helping the patients who would have no medical recourse in their rare disease battle. Jeffrey is achieving what large pharmaceutical companies and large biotech firms could not achieve, which is to get life-saving drugs and treatments approved and into the market quickly.

 

Jeffrey Aronin has years of experience in the pharmaceutical industry as a leading manager for the following biopharmaceutical companies:

 

* Castle Creek Pharmaceuticals

* Harmony Bioscience.

* Ovation Pharmaceuticals later acquired by Lundbeck, Inc.

 

Jeffrey Aronin has a Bachelor of Science degree from Northern Illinois University, a Master of Business Administration from DePaul University. He completed his post-graduate coursework at the Kellogg School of Management of Northwestern University and from the Booth School of Business of the University of Chicago.

 

Mr. Aronin is also the co-chairman and the founder of MATTER which is a new generation biotech firm. He is very involved with financial and medical organizations. Jeffrey is on the board of Discover Financial Services and Castle Creek Pharmaceuticals.

 

His board work continues as the director of the Economic Club of Chicago and the World Business Chicago. Aronin received the Crown Fellowship award from the Aspen Institute. He is a member of the Commercial Club and the Aspen Global Leadership Network.

 

Jeffrey is a regular lecturer at his post-graduate colleges – Kellogg School of Management and Booth School of Business. In 2017, Mr. Aronin was awarded the Weizmann Leadership Award from the Weizmann Institute of Science.

 

As a generous philanthropist, Jeffrey Aronin and his family supports research and patient-centered organizations like the Pediatric Epilepsy Research Foundation, the American Porphyria Foundation, and the Huntington’s Disease Society of America.